Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value: $482M (94.9% shares, 5.1% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | 5,597,065 | $72.51M | 15.1% | — | — | COM CL A | 46333X108 |
| — | RECEPTOS INC | 1,146,300 | $71.2M | 14.8% | — | — | COM | 756207106 |
| LGND | LIGAND PHARMACEUTICALS INC | 1,108,763 | $52.1M | 10.8% | — | — | COM NEW | 53220K504 |
| — | ARRAY BIOPHARMA INC | 13,876,513 | $49.54M | 10.3% | — | — | COM | 04269X105 |
| — | CHEMOCENTRYX INC | 8,596,772 | $38.69M | 8.0% | — | — | COM | 16383L106 |
| — | ONCOMED PHARMACEUTICALS INC | 1,287,847 | $24.38M | 5.1% | — | — | COM | 68234X102 |
| — | ONCOTHYREON INC | 9,867,278 | $18.95M | 3.9% | — | — | COM | 682324108 |
| — | FIVE PRIME THERAPEUTICS INC | 1,461,900 | $17.15M | 3.6% | — | — | COM | 33830X104 |
| — | TARGACEPT INC | 6,655,128 | $16.84M | 3.5% | — | — | COM | 87611R306 |
| — | LOXO ONCOLOGY INC | 1,192,202 | $15.65M | 3.3% | — | — | COM | 548862101 |
| — | CONCERT PHARMACEUTICALS INC | 1,206,459 | $15.21M | 3.2% | — | — | COM | 206022105 |
| — | ARRAY BIOPHARMA INC | 16,000,000 | $14.4M | 3.0% | — | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | EXELIXIS INC | 17,175,000 | $10.01M | 2.1% | — | — | NOTE 4.250% 8/1 | 30161QAC8 |
| — | QLT INC | 2,093,563 | $9.463M | 2.0% | — | — | COM | 746927102 |
| PRQR | PROQR THRAPEUTICS N V | 549,000 | $9.437M | 2.0% | — | — | SHS EURO | N71542109 |
| — | TREVENA INC | 1,118,743 | $7.182M | 1.5% | — | — | COM | 89532E109 |
| ARDX | ARDELYX INC | 453,541 | $6.445M | 1.3% | — | — | COM | 039697107 |
| CYTK | CYTOKINETICS INC | 1,527,000 | $5.375M | 1.1% | — | — | COM NEW | 23282W605 |
| — | VITAE PHARMACEUTICALS INC | 666,000 | $5.082M | 1.1% | — | — | COM | 92847N103 |
| — | ARQULE INC | 4,300,887 | $4.817M | 1.0% | — | — | COM | 04269E107 |
| — | REGADO BIOSCIENCES INC | 2,607,091 | $2.946M | 0.6% | — | — | COM | 75874Q107 |
| — | BIOLINERX LTD | 1,501,000 | $2.312M | 0.5% | — | — | SPONSORED ADR | 09071M106 |
| — | KALOBIOS PHARMACEUTICALS INC | 1,162,000 | $1.801M | 0.4% | — | — | COM | 48344T100 |
| — | ONCOGENEX PHARMACEUTICALS IN | 662,069 | $1.768M | 0.4% | — | — | COM | 68230A106 |
| — | SOPHIRIS BIO INC | 600,000 | $1.758M | 0.4% | — | — | COM NEW | 83578Q209 |
| — | REGULUS THERAPEUTICS INC | 184,999 | $1.264M | 0.3% | — | — | COM | 75915K101 |
| — | ACHAOGEN INC | 136,600 | $1.224M | 0.3% | — | — | COM | 004449104 |
| — | BIOTA PHARMACEUTIALS INC | 435,900 | $1.077M | 0.2% | — | — | COM | 090694100 |
| — | ANTHERA PHARMACEUTICALS INC | 559,624 | $1.074M | 0.2% | — | — | COM NEW | 03674U201 |
| QURE | UNIQURE NV | 106,500 | $981K | 0.2% | — | — | SHS | N90064101 |
| — | PALATIN TECHNOLOGIES INC | 750,655 | $698K | 0.1% | — | — | COM PAR $ .01 | 696077403 |
| — | TRANSCEPT PHARMACEUTICALS IN | 150,000 | $304K | 0.1% | — | — | COM | 89354M106 |